News
-
Botox no headache
Monday | Mar 3 2014From 01 Mar, Botox (botulinum toxin type A) will be listed on the Pharmaceutical Benefits Scheme.
-
Votrient PBS listing
Monday | Mar 3 2014Votrient (pazopanib hydrochloride) has been listed on the Pharmaceutical Benefits Scheme (PBS), from 01 Mar.
-
AMT 2.53 released
Monday | Mar 3 2014The Australian Medicines Terminology (AMT) 2.53 release can be downloaded from the NEHTA website.
-
Rare Disease Day
Monday | Mar 3 2014Keynote speaker of the GLOBALHealthPR annual meeting, which concluded on Rare Disease Day, Alexion Pharmaceuticals managing.
-
US nutrition labelling
Monday | Mar 3 2014The US Food & Drug Administration (FDA) has proposed to update the Nutrition Facts label for.
-
AHPRA members
Monday | Mar 3 2014The Australian Health Practitioner Regulation Agency will call for expressions of interest from pharmacists who wish.
-
FDA side effects open
Monday | Mar 3 2014US Food & Drug Administration (FDA) has unveiled a project named openFDA to create transparency and.
-
RGH update on Vit D
Monday | Mar 3 2014The Repatriation General Hospital Pharmacy E-Bulletin has provided an update on the use of vitamin D.
-
New $47m FK facility
Monday | Mar 3 2014Fresenius Kabi Australia is establishing a new $47 million state-of-the-art pharmaceutical manufacturing centre in Melbourne.
-
Calcium L-threonate
Monday | Mar 3 2014The Therapeutic Goods Administration has added the current compositional guideline and submissions received on the draft.